版本:
中国

BRIEF-Enanta Pharmaceuticals to present data on RSV inhibitor at annual RSV conference

Sept 29 Enanta Pharmaceuticals Inc:

* Presents data on a novel non-fusion inhibitor of Respiratory Syncytial Virus (RSV) at the 10th annual respiratory syncytial virus conference

* Further, EP-023938 maintained antiviral potency across all clinical isolates tested as well as virus that was resistant to fusion inhibitors

* Says lead compound shows promising anti-viral activity in rsv-A and rsv-B

* Says plans to continue evaluation of EP-023938 as a potential development candidate for RSV Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐